We quantified basal protein levels of total FAK and phosphorylated/activated FAK (Y397) in the fourteen breast cancer cell lines for which we had already assessed growth inhibition in response to rapamycin (Figure 2D and Supplementary Figure S2). Here, PTK2 is linked to breast carcinoma.